George Frangeskides, Exec-Chair at Alba Mineral Resources, discusses grades at the Clogau Gold Mine. Watch the full video here.
Worth noting that even though we received the shares at $5, the investment in CDT is actually in profit. At $3.63 is circa £2.95m bearing in mind our outlay was £2.75m. Based on the BoD investments to date that could be considered a homerun!! It also means the investment in CDT is more than our Mcap.....
SAN DIEGO and LONDON, March 19, 2024 (GLOBE NEWSWIRE) -- Conduit Pharmaceuticals Inc. (Nasdaq: CDT) ("Conduit Pharmaceuticals" or "Conduit" or the “Company”) today announced the appointment of Dr. Joanne Holland as Chief Scientific Officer.
Dr. Holland brings over 20 years of experience to the CSO role at Conduit, having amassed expertise across the entire development spectrum. This includes a deep knowledge base in identifying drugs that can be applied across multiple disease states, combining research and commercial skills to advance drugs to market, and working with premier scientific thought leaders. She has a specific focus in solid-form technology and its associated intellectual property, having held leadership positions at publicly traded companies in this space, as well as consulting roles for several pharmaceutical companies on all matters relating to solid-form technology. She has successfully shepherded multiple solid-form candidates from discovery stage into the clinic, and is the author of over 50 solid-form intellectual property patents. Dr. Holland earned a PhD in chemistry from the University of Leeds, UK, which was sponsored by Pfizer, Inc., before starting her career at companies including Millennium Pharmaceuticals and Stylacats Limited.
In addition, Conduit has engaged Dr. Jeff Lindeman to consult on intellectual property strategies as part of the Company’s research and development of its solid-form candidates. An international speaker, Dr. Lindeman has authored book chapters on patent strategies relating to pharmaceutical solid-state forms. Prior to opening his consulting firm Two Notch Solutions, LLC, in 2009, Dr. Lindeman founded and then successfully sold J.A. Lindeman & Co. PLLC (now Raphael Bellum PLLC) and has over 30 years of intellectual property law experience, including as an adjunct patent law professor at American University and as a United States patent examiner. His role with the Company is as a consultant, not legal counsel.
“The appointment of Jo as Chief Scientific Officer underscores Conduit’s commitment to optimizing the value of our current intellectual property assets, while concurrently fostering the creation of new intellectual property,” said Dr. David Tapolczay, Chief Executive Officer. “Jo and Jeff have over 20 years of experience working together, and their new leadership roles will significantly enhance our intellectual property state, strategically positioning Conduit for future out-licensing opportunities.”
Msuk.int you mentioned the chart looks good yesterday, what's happened? Please explain the lack of trades considering CDT just added circa £700k to our investments value?
I know you are a chartist and will not listen to anything else but sometimes maybe other things are in play that go towards explaining why the SP doesn't react how you think.
If anyone is interested in something other than charts:
At the closing price of CDT yesterday ($3.68) our holding there is worth £2.99m, our current MCap is £2.76m.
The current value of our investments + Cash is currently - £5.7m
The current sentiment in Vela is less than zero...
CDT just released news...... funnily enough if CDT moves up so does VELA. But if its just charts then CDT should not have any bearing on VELA as the charts don't rely on news or fundamentals as you have said previously....
Yes, unfortunately like the bulk of our investments we are heavily underwater. The upshot being that some have bounced off their bottom. MWE actually has paid us a dividend in the past as well!
MCap - £2.6m
Value of investments and cash - £5.05m
This is a discussion board. If all we spoke about was charts then there wouldn't be any chat. If charts are your thing then good on you.
Back to the facts of this share:
MCap - £2.3m
Value of investments & Cash - £5m
Currently valued at 45% of the asset value.
All at time of writing.
Hi Postman, everyone is entitled to their opinion. Most of the negativity is towards the BoD and rightly so.
I would say ramping with complete misinformation is worse though. Remember you saying VELA kept the royalty agreement for AZ1656 on top of getting the $4m worth of shares......
Mcap - £2.324m
Value of investment & Cash - £5.35m
Currently valued at 43% of assets.
What we are seeing is the result of an inept BoD and company which is so poorly run its a joke. We all knew they would be selling other investments to pay themselves but we are also seeing them selling at lows and realising losses. ENSI for example has been sold as recently as this year for around 48p, their SP today is 73p. They had the opportunity to sell some CDT at over $5 and provide some much needed funds but they decided against that.
As ever, all hopes are pinned on CDT and they will continue to sell other investments for losses to pay themselves until (hopefully) CDT comes good.
Hopefully Chris Cooke has a plan while he accumulates shares.
All figures are at time of writing.
Still here but there is more important thing in life then watching this company being run into the ground. Terrible RNS as we knew it would be. Continually selling existing investments at losses to pay for the terrible board to run this company down. CDT remains the only hope.
Look forward to the issuing of new shares to pay for the £50k they spent on advisors. Remind me what we are paying the BoD for again?
Completely agree Bouncer, although you have to factor in the number of mistakes the BoD have made and continue to make. They could have sold some CDT shares to cover costs but decided to gamble and that hasn't paid off as they will be selling other shares at a loss to cover overheads now.
The website is not up to date and around a year out of date. The quarterly reports are often 2-3 months after the quarter end which could be forgiven if our BoD were hard at work, but as mentioned we haven't had to invested in a new company for 9 months and we have no cash to invest anyway, so what exactly are the 3 directors doing to earn their cash?!
Such a frustrating share because if it was run correctly the outlook would look so much better.
Completely agree Jim. they have no skin in the game so why would they care what the SP does, as long as they still have investments they can sell to pay themselves they will keep it going. Laiker had skin in the game then proceeded to be able to offload all his holding at a premium to the SP at the time. It feels corrupt!
Yeah I've been thinking the same. I can blame the BoD but they aren't asking me to stay invested! In fact judging by their actions you would be forgiven for thinking they want us all to sell!
Hard to see any positives here currently and based on what Dave posted, doesn't look like there will be much going on with CDT for the foreseeable. Imagine if the BoD had actually sold some while the SP was over $5 - should of, would of, could of